Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Lima HA, Moazzam Z, Endo Y, et al. TBS-based preoperative score to predict non-transplantable recurrence and identify candidates for upfront resection versus transplantation for hepatocellular carcinoma. Ann Surg Oncol. 2023;30(6):3363–73.

Article  PubMed  Google Scholar 

Lin C, Song W, Bi X, et al. Recent advances in the ARID family: focusing on roles in human cancer. Onco Targets Ther. 2014;7:315–24.

PubMed  PubMed Central  Google Scholar 

Wilsker D, Probst L, Wain HM, et al. Nomenclature of the ARID family of DNA-binding proteins. Genomics. 2005;86(2):242–51.

Article  CAS  PubMed  Google Scholar 

Guan B, Wang TL, Shih Ie M. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 2011;71(21):6718–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamakawa T, Waer C, Itakura K. AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells. Prostate. 2018;78(16):1238–47.

Article  CAS  PubMed  Google Scholar 

Liao TT, Hsu WH, Ho CH, et al. let-7 modulates chromatin configuration and target gene repression through regulation of the ARID3B complex. Cell Rep. 2016;14(3):520–33.

Article  CAS  PubMed  Google Scholar 

Winter SF, Lukes L, Walker RC, Welch DR, Hunter KW. Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. PLoS Genet. 2012;8(5):e1002735.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo SM, Tsai WC, Tsai CK, Chen Y, Hueng DY. ARID4B knockdown suppresses PI3K/AKT signaling and induces apoptosis in human glioma cells. Onco Targets Ther. 2021;14:1843–55.

Article  PubMed  PubMed Central  Google Scholar 

Miao X, Xi Z, Zhang Y, et al. Circ-SMARCA5 suppresses colorectal cancer progression via downregulating miR-39-3p and upregulating ARID4B. Dig Liver Dis. 2020;52(12):1494–502.

Article  CAS  PubMed  Google Scholar 

Wu MY, Eldin KW, Beaudet AL. Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes. J Natl Cancer Inst. 2008;100(17):1247–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang YK, Han ZD, Lu JM, et al. Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer. J Cell Biochem. 2018;119(9):7245–55.

Article  CAS  PubMed  Google Scholar 

Wu RC, Young IC, Chen YF, et al. Identification of the PTEN-ARID4B-PI3K pathway reveals the dependency on ARID4B by PTEN-deficient prostate cancer. Nat Commun. 2019;10(1):4332.

Article  PubMed  PubMed Central  Google Scholar 

Sun J, Cheng NS. Comprehensive landscape of ARID family members and their association with prognosis and tumor microenvironment in hepatocellular carcinoma. J Immunol Res. 2022;2022:1688460.

Article  PubMed  PubMed Central  Google Scholar 

Subbiah IM, Falchook GS, Kaseb AO, et al. Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. Oncotarget. 2015;6(29):28453–62.

Article  PubMed  PubMed Central  Google Scholar 

Paskeh MDA, Ghadyani F, Hashemi M, et al. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: promises and challenges. Pharmacol Res. 2023;187:106553.

Article  CAS  PubMed  Google Scholar 

Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169(6):589–94.

Article  CAS  PubMed  Google Scholar 

Wakabayashi G, Cherqui D, Geller DA, et al. The Tokyo 2020 terminology of liver anatomy and resections: updates of the Brisbane 2000 system. J Hepatobiliary Pancreat Sci. 2022;29(1):6–15.

Article  PubMed  Google Scholar 

Yanagaki M, Haruki K, Taniai T, et al. The significance of osteosarcopenia as a predictor of the long-term outcomes in hepatocellular carcinoma after hepatic resection. J Hepatobiliary Pancreat Sci. 2023;30(4):453–61.

Article  PubMed  Google Scholar 

Kudo M, Kitano M, Sakurai T, Nishida N. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the liver cancer study group of Japan. Dig Dis. 2015;33(6):765–70.

Article  PubMed  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

Article  PubMed  PubMed Central  Google Scholar 

Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6(2):8.

Article  Google Scholar 

Yanagaki M, Shirai Y, Shimada Y, et al. Inhibition of lysosomal acid β-glucosidase induces cell apoptosis via impairing mitochondrial clearance in pancreatic cancer. Carcinogenesis. 2022;43(9):826–37.

Article  CAS  PubMed  Google Scholar 

Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.

Article  CAS  PubMed  Google Scholar 

Fleischer TC, Yun UJ, Ayer DE. Identification and characterization of three new components of the mSin3A corepressor complex. Mol Cell Biol. 2003;23(10):3456–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu R, Wang GG. Tudor: a versatile family of histone methylation “readers.” Trends Biochem Sci. 2013;38(11):546–55.

Article  CAS  PubMed  Google Scholar 

Nishibuchi G, Nakayama J. Biochemical and structural properties of heterochromatin protein 1: understanding its role in chromatin assembly. J Biochem. 2014;156(1):11–20.

Article  CAS  PubMed  Google Scholar 

Buurman R, Gürlevik E, Schäffer V, et al. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology. 2012;143(3):811-820.e815.

Article  CAS  PubMed  Google Scholar 

Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74–88.

Article  CAS  PubMed  Google Scholar 

Chen H, Huang Y, Huang J, Lin L, Wei G. Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-κB signaling pathway. Oncol Rep. 2017;37(2):865–70.

Article  CAS  PubMed  Google Scholar 

Lee S, Choi EJ, Cho EJ, et al. Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway. Clin Mol Hepatol. 2020;26(4):529–39.

Article  PubMed  PubMed Central  Google Scholar 

Zhou SL, Zhou ZJ, Hu ZQ, et al. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett. 2015;